Pfizer, Astellas prostate cancer drug promising in late-stage trial
Pfizer and Astellas jointly sell Xtandi in the US, while Astellas owns the rights to develop and sell Xtandi outside the US
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
CCI to study pricing issue in pharma, healthcare sector
The proposal, mooted by the regulator, comes amid concerns over anti-competitive practices in the pharmaceutical and healthcare…
Lupin Pharmaceuticals recalls 12,888 bottles of ulcer drug in US
The reason for the recall is current CGMP deviations
IDMA-NSF programme to inaugurate on Sept 25
The first module for the first batch will start on Sept 26
Lupin gets US FDA nod to market generic anti-bacterial drug
The product is a generic version of GD Searle's Flagyl tablets
Ministry of AYUSH conducts online article writing contests on prevention and management of diabetes
Special Secretary AYUSH gives away prizes to winners of the contest
Merck announces findings from Phase III study of KEYTRUDA
The findings include updated survival data showing a 19 per cent reduction in the risk of death over standard treatment in the…
Aurigene, Curis to expand CA-170 clinical trial to India
Selected populations of patients to be treated at major cancer centres with the potential checkpoint inhibitor as a once daily…
Key process to be modernised in production of lifesaving drugs, food preservation
The process, called 'lyophilisation,' removes water at low temperature and pressure
AYUSH minister inaugurates India’s first advanced homoeopathy virology lab in Kolkata
New drugs and technologies will be developed in homoeopathy to combat emerging challenges of viral diseases
AstraZeneca’s Global Medicines Development group to expand in Bengaluru
The types of roles include: regulatory professionals, regulatory project managers and leaders and physicians
Strides Shasun receives USFDA approval for Potassium Citrate Extended-Release Tablets
The tablets will be available in 5 mEq, 10 mEq, and 15 mEq
Lupin gets USFDA nod to market anti-infections tablets
The company’s product is a generic version of Pfizer's Vibra tablets
Lupin has received approval from the US health regulator to…
Sanofi launches Combiflam ICYHOT
The over-the-counter (OTC) product is available in two formats – gel and spray
Laurus Infosystems launches Smart MES Software
Valuable insights were shared during the launch event
Gufic Biosciences to tap generics, life-saving products segment in Africa, Asian markets
The company plans to provide high-end injections
Merck in agreement with Natrix Separations
The acquisition boosts Merck’s single-use chromatography portfolio and accelerates mAb and vaccine manufacturing offering
British Biologicals organises nutrition awareness rally in Bengaluru
The seven-day event held with seven different nutrition concepts for in-house members, which brought awareness as well as…
US FDA warns of problems with EpiPen manufacturing plant
Tens of thousands of EpiPens, sold by Mylan NV, were recalled worldwide in March following two reports of the life-saving allergy…
Purdue University scientists find breakthrough in treating obesity and diabetes
Nanoparticle-drug combo turns white fat to brown fat with potential to treat obesity, diabetes